دوره 6، شماره 2 - ( 3-1396 )                   جلد 6 شماره 2 صفحات 45-29 | برگشت به فهرست نسخه ها

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Omer A M. Faking and counterfeiting of drugs: Evaluation of Pharmacy Regulatory, Privatisation, Social Welfare Services and Its Alternatives of Sudan. J Emerg Health Care 2017; 6 (2) :29-45
URL: http://intjmi.com/article-1-269-fa.html
Faking and counterfeiting of drugs: Evaluation of Pharmacy Regulatory, Privatisation, Social Welfare Services and Its Alternatives of Sudan. . 1396; 6 (2) :29-45

URL: http://intjmi.com/article-1-269-fa.html


چکیده:   (7885 مشاهده)
The strategy of price liberalisation and privatisation had been implemented in Sudan over the last decade, and has had a positive result on government deficit. The investment law approved recently has good statements and rules on the above strategy in particular to pharmacy regulations. Under the pressure of the new privatisation policy, the government introduced radical changes in the pharmacy regulations. To improve the effectiveness of the public pharmacy, resources should be switched towards areas of need, reducing inequalities and promoting better health conditions. Medicines are financed either through cost sharing or full private. The role of the private services is significant. A review of reform of financing medicines in Sudan is given in this study. Also, it highlights the current drug supply system in the public sector, which is currently responsibility of the Central Medical Supplies Public Corporation (CMS). In Sudan, the researchers did not identify any rigorous evaluations or quantitative studies about the impact of drug regulations on the quality of medicines and how to protect public health against counterfeit or low quality medicines, although it is practically possible. However, the regulations must be continually evaluated to ensure the public health is protected against by marketing high quality medicines rather than commercial interests, and the drug companies are held accountable for their conduct.
     
نوع مطالعه: مروری | موضوع مقاله: عمومى

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.